MEDP stock forecast
Our latest prediction for Medpace Holdings Inc's stock price was made on the Sept. 27, 2022 when the stock price was at 147.03$.
In the short term (2weeks), MEDP's stock price should outperform the market by 0.64%. During that period the price should oscillate between -8.84% and +5.63%.
In the medium term (3months), MEDP's stock price should outperform the market by 4.23%. During that period the price should oscillate between -28.23% and +22.07%.Get email alerts
Create a solid portfolio with MEDP
About Medpace Holdings Inc
Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace's mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages regulatory and therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 3,400 people across 37 countries.
At the moment the company generates 163M USD in revenues.
On its last earning announcement, the company reported a profit of 6.01$ per share.
The book value per share is 15.18$
Three months stock forecastSept. 27, 2022
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|